[1] Liu T,Liu M,Dai Y. γεT Cell is impacted to erythropoies suppression in patient with acquired pure red cell aplastic anemia. Blood, 2004,13b
[2] Liu T, Xu F, Zhu HL. Analysis of T cell subets and CD3S chain expression in myelodysplastic syndromes patients. Blood, 2003,102(11)
[3] Niu T,Wei YQ, Liu T.Construction of a recombinant protein vaccine based on xenopus homologous vascular endothelial growth factor(VEGF) and its antitumor efficacy. Blood, 2002,100(11)
[4] Gong YP, Liu T, Jia YQ.Comparison of Pgp- and MRP-mediated multidrug resistance in leukemia cell lines. Int J Hematol, 2002,75(2)
[5] Yang YM, Liu T. Study on anti-leukemia effect of tanshinone IIA in vitro and in vivo to acute promyelocytic leukemia. Blood, 2000,94(10)
[6] Liu T, Jia YQ. Hematopoietic chimerism and clinical outcome after allogeneic peripheral blood stem cell transplantation with MMC conditioning regimen. Blood, 2000,94(10)
[7] Liu T. MMC conditioning regimen (melphalan, MeCCNU and cyclophos phamide) followed by allogeneic peripheral blood stem cells transplantation for chronic myeloid leukemia. Blood, 1998,92(10)
[8] 邹文蓉,刘霆,孟文彤,余江,牛挺.骨髓增生异常综合征患者骨髓血管新生的初步观察.四川大学学报（医学版), 2005,36(1)
[9] 刘霆,李建军,贾永前,徐才刚,向兵.异基因造血干细胞移植治疗白血病临床总结.四川医学, 2004,25(3)
[10] 孟文彤,刘霆,李建军,史青,向兵.初发慢性髓系白血病bcr/abl融合基因转录子与临床关系的观察.四川医学, 2004,25(3)
[11] 谭竞,刘霆.多发性骨髓瘤的非细胞毒性治疗的基础和临床研究进展.四川医学, 2004,25(6)
[12] 李建军,刘霆,吴谨绪.骨髓增生异常综合征发病机制及治疗的研究进展.四川医学, 2004,25(3)
[13] 许芳,刘霆,朱焕玲,崔旭www.med126.com,徐才刚.骨髓增生异常综合征患者T细胞亚型和CD3zeta 表达的分析.中国实验血液学杂志, 2004,12(6)
[14] 代阳,刘霆,朱焕玲,崔旭,徐才刚.获得性纯红再障患者外周血T细胞亚群分析.四川医学, 2004,25(3)
[15] 刘霆,吴谨绪.我省血液病学发展应重视普及与提高相结合.四川医学, 2004,25(3)
[16] 陈心传,刘霆,崔旭.伊马替尼治疗慢性粒细胞白血病出现脑水肿一例.中华血液学杂志, 2004,25(7)
[17] 汪宇春,刘霆,张霁.STR-PCR定量分析非清髓性干细胞移植后造血嵌合体.四川大学学报(医学版), 2003,34(3)
[18] 刘霆,廖小梅,黄杰.非清髓性干细胞移植治疗骨髓增生异常综合征二例.中华内科杂志, 2002,41(4)
[19] 刘霆.造血干细胞移植中输血的特点和应用.中国输血杂志, 2002,14(5)
[20] 刘霆.造血干细胞移植中输血的特点和应用.中国输血杂志, 2001,14(5)刘霆.非何杰金恶性淋巴瘤病理分型及其治疗进展.四川医学, 2001,22(8)
[21] 刘霆,贾永前,徐才刚.非血缘供者异基因骨髓移植治疗慢性粒细胞白血病.华西医科大学学报, 2000,31(4)
[22] 刘霆,余喜讯,赵长生.聚醚砜中空纤维膜血浆分离器血浆分离功能与血液相容性的评价.生物医学工程学杂志, 2000,17(3)
联系方式:
电话： 028-85422364 　　　邮箱:Tingliu@mail.sc.cninfo.net